A dangerous deal for labor, the Trans Pacific Partnership free trade agreement, gained a key endorsement from the NYTimes on the eve of VP Biden’s trip to China. Ed Schultz and Leo Gerard discuss the effect.

"A US-led trade deal is currently being negotiated that could increase the price of prescription drugs, weaken financial regulations and even allow partner countries to challenge American laws. But few know its substance."